HOME >> MEDICINE >> NEWS
Study shows use of budesonide reduced the risk of asthma related events by 40% in children

San Antonio, Tex., - March 19, 2005 New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.

The findings, presented today at the 61st annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), are from two analyses of the Inhaled Steroid as Regular Therapy in Early Asthma (START) study, a three-year trial involving nearly 2,000 children aged 5 to 10 years with mild persistent asthma. The START study was funded by AstraZeneca.

"Many children with asthma make repeated trips to the emergency room or are hospitalized because of worsening symptoms," said Dr. Albert Sheffer, Clinical Professor of Medicine at Harvard Medical School, Director Emeritus at the Allergy Clinic, Brigham and Women's Hospital in Boston and an investigator in the safety and tolerability portion of the study. "The findings of these two analyses showed that budesonide had a viable long-term treatment effect."

In the first analysis, 1,974 children were randomized to receive either once-daily budesonide or placebo in addition to usual asthma care. The earlier use of budesonide reduced the risk of exacerbation, or severe asthma related events by 40 percent compared to usual asthma care. In addition, children in the budesonide group required fewer interventions with other inhaled corticosteroids (12.3 percent versus 22.7 percent for placebo), and had improved lung function.

The second analysis tracked the adverse side effects reported by 1,981 children taking either budesonide plus usual care or placebo over three years. Overall, the incidence of side effects was comparable between the two groups, with fewer asthma exacerbations and adverse events reported in the budesonide group throughout
'"/>

Contact: Heather Law
heather.law@astrazeneca.com
302-886-1652
Burson-Marsteller
21-Mar-2005


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
10. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
11. Study of obese diabetics explains why low-carb diets produce fast results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 04, 2019 , ... Now a patented ... from disruptions to cells and tissue and inflammation that leads to Jet Lag ... available in a dietary supplement product called Prepair™ . , Today, millions ...
(Date:12/4/2019)... ... December 04, 2019 , ... Healthcare ... Awards™, the only national awards dedicated to recognizing excellence in the areas of ... were presented in nine different categories during the GlobeSt Healthcare Conference today in ...
(Date:12/4/2019)... and CHAPEL HILL, N.C. (PRWEB) , ... December 04, 2019 , ... ... patients and their families easily find their way around the campuses of UNC Medical ... turn-by-turn navigation inside the two hospitals, parking garages, clinics and more. , The free ...
(Date:12/2/2019)... ... ... More than $400 million dollars are forfeited in FSA funds to the use-it-or-lose-it ... funds throughout the year, many more wait to the last-minute --- sometimes even right ... holders use -- not lose -- their funds this year, FSAstore.com is ...
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... Interim ... a silver winner of the 2019 Workforce: Optimas Awards . Selected for its ... first and foremost to help combat the nation’s caregiver shortage. By 2025, the U.S. ...
Breaking Medicine News(10 mins):
(Date:12/2/2019)... (PRWEB) , ... December 02, 2019 , ... Today asensei, ... to offer a complete solution for digital fitness experience creators. , As more and ... upon which companies can differentiate their products and decrease time to market. This partnership ...
(Date:11/30/2019)... ... November 29, 2019 , ... ACC Medlink has been waiting more than two ... Amazon’s incredibly large purchase of these vehicles for their Prime delivery services. ... received word on vehicle availability and are expecting to have the new 2020 Mercedes ...
(Date:11/27/2019)... , ... November 27, 2019 , ... ... to help those suffering from extreme dry skin disorders. Urea is a ... grail ingredient provides intensive hydration to restore moisture balance for consumers with very ...
Breaking Medicine Technology:
Cached News: